Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia (original) (raw)
Al Khatib SM, LaPointe NM, Kramer JM, Califf RM . What clinicians should know about the QT interval. JAMA 2003; 289: 2120–2127. ArticlePubMed Google Scholar
Paulussen ADC, Gilissen RAHJ, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJM et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med 2004; 82: 182–188. ArticleCASPubMed Google Scholar
Zareba W, Lin DA . Antipsychotic drugs and QT interval prolongation. Psychiatr Q 2003; 74: 291–306. ArticlePubMed Google Scholar
Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002; 105: 1943–1948. ArticleCASPubMed Google Scholar
Farkas A, Coker SJ . Prevention of clofilium-induced torsades de pointes by prostaglandin E2 does not involve ATP-dependent K+ channels. Eur J Pharmacol 2003; 472: 189–196. ArticleCASPubMed Google Scholar
Cutler AJ, Kalali AH, Weiden P, Hamilton J, Wolfgang CD . Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia. J Clin Psychopharmacol 2008; 28 (Suppl 1): S20–S28. ArticleCASPubMed Google Scholar
Di X, Matsuzaki H, Webster TA, Hubbell E, Liu G, Dong S et al. Dynamic model based algorithms for screening and genotyping over 100K SNPs on oligonucleotide microarrays. Bioinformatics 2005; 21: 1958–1963. ArticleCASPubMed Google Scholar
Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57: 289–300. Google Scholar
Weller JI, Song JZ, Heyen DW, Lewin HA, Ron M . A new approach to the problem of multiple comparisons in the genetic dissection of complex traits. Genetics 1998; 150: 1699–1706. CASPubMedPubMed Central Google Scholar
Mosig MO, Lipkin E, Khutoreskaya G, Tchourzyna E, Soller M, Friedmann A . A whole genome scan for quantitative trait loci affecting milk protein percentage in Israeli-Holstein cattle, by means of selective milk DNA pooling in a daughter design, using an adjusted false discovery rate criterion. Genetics 2001; 157: 1683–1698. CASPubMedPubMed Central Google Scholar
Bornancin F, Mechtcheriakova D, Stora S, Graf C, Wlachos A, Devay P et al. Characterization of a ceramide kinase-like protein. Biochim Biophys Acta 2005; 1687: 31–43. ArticleCASPubMed Google Scholar
Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308–311. ArticleCASPubMedPubMed Central Google Scholar
Chapman H, Ramstrom C, Korhonen L, Laine M, Wann KT, Lindholm D et al. Downregulation of the HERG (KCNH2) K+ channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation. J Cell Sci 2005; 118: 5325–5334. ArticleCASPubMed Google Scholar
Hida H, Takeda M, Soliven B . Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes. J Neurosci 1998; 18: 8712–8719. ArticleCASPubMedPubMed Central Google Scholar
Chik CL, Li B, Karpinski E, Ho AK . Ceramide inhibits the outward potassium current in rat pinealocytes. J Neurochem 2001; 79: 339–348. ArticleCASPubMed Google Scholar
Ceramide kinase-like protein. Human Protein Reference Database Web site. Available at http://www.hprd.org. Accessed 7 August 2007.
Adachi H, Suzuki T, Abe M, Asano N, Mizutamari H, Tanemoto M et al. Molecular characterization of human and rat organic anion transporter OATP-D. Am J Physiol Renal Physiol 2003; 285: F1188–F1197. ArticleCASPubMed Google Scholar
Thiemermann C, Zacharowski K . Selective activation of E-type prostanoid3-receptors reduces myocardial infarct size: a novel insight into the cardioprotective effects of prostaglandins. Pharmacol Ther 2000; 87: 61–67. ArticleCASPubMed Google Scholar
Ladd AN, Charlet BN, Cooper TA . The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 2001; 21: 1285–1296. ArticleCASPubMedPubMed Central Google Scholar
Lu X, Timchenko NA, Timchenko LT . Cardiac _elav_-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum Mol Genet 1999; 8: 53–60. ArticleCASPubMed Google Scholar
Ladd AN, Taffet G, Hartley C, Kearney DL, Cooper TA . Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol Cell Biol 2005; 25: 6267–6278. ArticleCASPubMedPubMed Central Google Scholar
Philips AV, Timchenko LT, Cooper TA . Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998; 280: 737–741. ArticleCASPubMed Google Scholar
Li D, Bachinski LL, Roberts R . Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia. Genomics 2001; 74: 396–401. ArticleCASPubMed Google Scholar
Ladd AN, Stenberg MG, Swanson MS, Cooper TA . Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn 2005; 233: 783–793. ArticleCASPubMed Google Scholar
Carteron C, Ferrer-Montiel A, Cabedo H . Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 2006; 119: 898–909. ArticleCASPubMed Google Scholar
Panchal H, Wansbury O, Parry S, Ashworth A, Howard B . Neuregulin3 alters cell fate in the epidermis and mammary gland. BMC Dev Biol 2007; 7: 105. ArticlePubMedPubMed Central Google Scholar
Révillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP . ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Ann Oncol 2008; 19: 73–80. ArticlePubMed Google Scholar
Zhao Y-Y, Sawyer DR, Baliga RR, Opel DJ, Han X, Marchionni MA et al. Neuregulins promote survival and growth of cardiac myocytes: persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998; 273: 10261–10269. ArticleCASPubMed Google Scholar
Shiffman D, Ellis SG, Rowland CM, Malloy MJ, Luke MM, Iakoubova OA et al. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 2005; 77: 596–605. ArticleCASPubMedPubMed Central Google Scholar
Jin L, Kern MJ, Otey CA, Wamhoff BR, Somlyo AV . Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner paladin to promote cell migration. Circ Res 2007; 100: 817–825. ArticleCASPubMed Google Scholar
Arking DE, Pfeufer A, Post W, Kao WHL, Newton-Cheh C, Ikeda M et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 2006; 38: 644–651. ArticleCASPubMed Google Scholar